Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Elm Street Ventures, founded in 2006, is a Yale-focused venture fund based in New Haven, Connecticut. The firm primarily invests in seed and early-stage companies, particularly those connected to Yale University. Their investment range is between $500,000 and $1 million.
This fund targets companies with ties to Yale, especially those utilizing technology licensed from the university. Elm Street Ventures also considers startups in the greater New Haven area and exceptional non-Yale/non-New Haven companies where they can provide significant value. Key sectors include biotech, healthcare, climate, clean energy, and SaaS.
Notable portfolio companies include Arvinas, focused on cancer treatment through a novel protein degradation platform; P2 Science, developing green chemistry solutions; Allyx, targeting neurodegenerative diseases; Halda, utilizing a RIPTAC mechanism for cancer treatment; and Cybrexa, which leverages low-pH tumor microenvironments for selective targeting.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.